Residential Inpatient Drug and Alcohol Addiction …
Residential Inpatient Drug and Alcohol Addiction …
Miramar Treatment 866.382.5442 | www.miramarlagunabeach.com The residential inpatient alcohol and drug
addiction treatment process varies significantly amongst drug and alcohol rehab programs, but quality programs should provide most of the following addiction treatment services initial assessment and evaluation by physicians and psychologists; detoxification from drugs or alcohol, when indicated; establishment of a comprehensive addiction treatment plan; execution of the addiction treatment plan with a focus on individual therapy; and development of a comprehensive addiction treatment discharge plan. www.miramarlagunabeach.com
Video Rating: 4 / 5
News Update: New Study Shows GlaxoSmithKline Plc’s Diabetes Drug Avandia Linked to Heart Risk (GSK)
A study in the Journal of the American Medical Association (JAMA) Monday links GlaxoSmithKline Plc’s (NYSE:GSK) Avandia diabetes drug to heart risk. Avandia is a commonly prescribed diabetes drug that, according to the study, increases the risks of heart disease, stroke and death. The study examined about a quarter million Type 2 diabetes patients taking two different diabetes drugs, and found that Avandia lead to a 25% greater risk of heart failure versus the competing drug, Actos; a 27% greater risk of stroke was also evident in Avandia patients. Avandia has been criticized in the past for harmful side effects – a New England Journal of Medicine study suggested the same findings as the JAMA study in 2007, which lead to a Food and Drug Administration (FDA) investigation. Doctors who took part in the JAMA study are wondering why diabetic patients are being prescribed Avandia, given there are other drugs on the market with less harmful side effects. “What we’re reporting in this study today was available to the FDA in 2007,” said Dr. David Graham from the Maryland-based Center for Drug Evaluation and Research at the FDA. “That keeps unsafe drugs on the market and patients are the ones who suffer,” added Graham. Director of the Cardiac Intensive Care Unit at St. Louis-based Washington University School of Medicine, Dr. Richard Bach, disagrees, saying, “I think the data is inconclusive. A physician should consider the weight of that evidence and the fact that it’s been …
-
The Construction & Operation of Clandestine Drug Laboratories drug design – click on the image... Read Full Story » -
The first sign of serious side effects was admitted by GlaxoSmithKline way back in... Read Full Story » -
by Coal and Ice I want to know what is in the drug that the FDA re called it is called DIGITEC... Read Full Story »
